Laser surgery for enlarged prostate (BPH) has moved from a specialized alternative procedure to a mainstream treatment option at major urology centers over the past decade. The range of laser techniques now available, each with different mechanisms, evidence bases, and clinical applications, means that 'laser surgery for enlarged prostate' is not a single procedure but a category that requires careful evaluation.
Where the Interest in Laser Comes From
Interest in laser surgery for enlarged prostate has grown primarily because of the perceived advantages over traditional transurethral resection of the prostate (TURP): shorter hospital stay, lower blood loss, earlier catheter removal, and preserved sexual function in most patients. These advantages are real for specific laser approaches and specific patient profiles, but they are not universal across all laser techniques and all patients.
What Industry Leaders Know
According to the European Association of Urology Guidelines, Holmium Laser Enucleation of the Prostate (HoLEP) has equivalent long-term efficacy to TURP and open prostatectomy for large-gland BPH and is now recommended as the reference procedure for large prostate glands (over 80 mL volume) at centers with HoLEP expertise. GreenLight laser (photoselective vaporization) is an alternative for smaller glands and patients with higher bleeding risk, with the advantage of lower blood transfusion rates but potentially lower durability of effect compared to resection techniques.
The evidence hierarchy in laser surgery for enlarged prostate is important for patients to understand. HoLEP has the most robust long-term data and is guideline-recommended for large glands. GreenLight has solid evidence for moderate-size glands, particularly in patients on anticoagulants. Thulium laser and diode laser techniques have emerging evidence but less long-term data than either HoLEP or GreenLight.
The Principles Behind an Informed Choice
Choosing among laser surgery options for enlarged prostate requires understanding three technical variables. First, gland size: HoLEP is designed for large prostates (over 80 mL) and consistently outperforms other approaches at this gland volume. For smaller glands, multiple approaches have equivalent outcomes and the choice depends more on surgeon expertise and patient preferences.
Second, bleeding risk: patients on anticoagulants (blood thinners) or antiplatelet medications for cardiac or vascular conditions present a significant bleeding risk for TURP. Laser techniques, particularly GreenLight, have lower blood loss and can often be performed without anticoagulant interruption, which is a meaningful safety advantage for this patient group.
Third, surgeon expertise: laser techniques for enlarged prostate have steep learning curves. HoLEP in particular requires approximately 50 to 80 cases for a surgeon to achieve consistent outcomes. A surgeon who is relatively early in their HoLEP experience will produce different outcomes than one who has performed several hundred cases. The volume and experience of the surgeon at the specific center matters more for laser procedures than for standard TURP, where the technique is more widely mastered.
How to Evaluate Your Options
1. Ask your urologist specifically which laser technique they are recommending and why it is the appropriate choice for your prostate size and health profile.
2. Ask for the specific surgeon's volume: how many cases of this specific procedure have they performed, and what are their reported rates for key outcomes (catheter removal time, continence recovery, reoperation rate)?
3. Ask whether the specific technique recommended is guideline-endorsed for your prostate volume. If your prostate exceeds 80 mL and the recommendation is GreenLight rather than HoLEP or open surgery, ask for the clinical rationale.
4. Confirm the hospital's protocol for managing anticoagulant medications around the procedure if this applies to you. The approach to anticoagulant management differs between laser techniques and between hospitals and should be explicitly discussed before the procedure date.
Recovery and Outcomes
Recovery from laser surgery for enlarged prostate is generally faster than from TURP. Most patients go home with a catheter that is removed within 24 to 48 hours, compared to 2 to 3 days for standard TURP. Physical activity restriction is typically 2 to 4 weeks versus 4 to 6 weeks for TURP. Retrograde ejaculation occurs in a proportion of laser surgery patients (lower than TURP for some techniques, comparable for others) and is an irreversible side effect that should be discussed before the procedure.
The expected symptom improvement from laser surgery for enlarged prostate is sustained over long follow-up periods in the procedures with the most data. HoLEP 10-year data shows durable symptom scores comparable to open surgery. GreenLight 5-year data shows good durability with a retreatment rate that is somewhat higher than resection techniques. Patients should understand the long-term outcome data for their specific planned procedure when making the treatment decision.
The Fundamental Question
The fundamental question in laser surgery for enlarged prostate is not 'laser or no laser' but 'which laser technique, at which center, with which surgeon experience level, for my specific prostate size and health profile?' The answer to this question, pursued through a direct and specific conversation with your urologist, produces a better treatment decision than any general comparison between laser and conventional approaches.